Gene · 2829
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detecting tipping points of complex diseases by network information entropy. | Brief Bioinform | 2024 | 38960408 | PubTator, text mining | PubMed |
| Inflammatory response in traumatic brain and spinal cord injury: The role of XCL1-XCR1 axis and T cells. | CNS Neurosci Ther | 2024 | 38887195 | PubTator, text mining | PubMed |
| XCR1: A promising prognostic marker that pinpoints targeted and immune-based therapy in hepatocellular carcinoma. | Heliyon | 2024 | 38868008 | PubTator, text mining | PubMed |
| Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration. | Signal Transduct Target Ther | 2024 | 38811552 | PubTator, text mining | PubMed |
| Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer. | EBioMedicine | 2024 | 38728838 | PubTator, text mining | PubMed |
| Metamorphic proteins and how to find them. | Curr Opin Struct Biol | 2024 | 38537533 | PubTator, text mining | PubMed |
| Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell-Mediated T-Cell Responses. | Clin Cancer Res | 2024 | 38488815 | PubTator, text mining | PubMed |
| Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9-expressing conventional type-1 dendritic cells. | Int J Cancer | 2024 | 38346928 | PubTator, text mining | PubMed |
| Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma. | Sci Rep | 2024 | 38287061 | PubTator, text mining | PubMed |
| The characteristics of cerebrospinal fluid tumor microenvironment in a patient with leptomeningeal metastases from cancer of unknown primary. | Genes Dis | 2024 | 38274387 | PubTator, text mining | PubMed |
| The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: A global review. | J Clin Lab Anal | 2024 | 38251811 | PubTator, text mining | PubMed |
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor. | J Exp Clin Cancer Res | 2024 | 38245792 | PubTator, text mining | PubMed |
| The origin, evolution, and molecular diversity of the chemokine system. | Life Sci Alliance | 2024 | 38228369 | PubTator, text mining | PubMed |
| Gel-mediated recruitment of conventional type 1 dendritic cells potentiates the therapeutic effects of radiotherapy. | Biomaterials | 2024 | 38228027 | PubTator, text mining | PubMed |
| Human genetic determinants of COVID-19 in Brazil: challenges and future plans. | Genet Mol Biol | 2024 | 38226654 | PubTator, text mining | PubMed |
| Novel lncRNA regulatory elements in milk somatic cells of Holstein dairy cows associated with mastitis. | Commun Biol | 2024 | 38225372 | PubTator, text mining | PubMed |
| Activation-neutral gene editing of tonsillar CD4 T cells for functional studies in human ex vivo tonsil cultures. | Cell Rep Methods | 2024 | 38211593 | PubTator, text mining | PubMed |
| Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models. | Cancer Biol Ther | 2024 | 38206570 | PubTator, text mining | PubMed |
| Proinflammatory chemokine CXCL14 activates MAS-related G protein-coupled receptor MRGPRX2 and its putative mouse ortholog MRGPRB2. | Commun Biol | 2024 | 38184723 | PubTator, text mining | PubMed |
| Emerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: A bibliometric analysis. | Endocrinol Diabetes Metab | 2024 | 37941122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/papers?page=5